on OXURION (EBR:OXUR)
Oxurion Releases 2025 Annual Report and Convenes Shareholders' Meeting
Oxurion NV, a pharmaceutical outsourcing company based in Leuven, Belgium, has published its annual report for the financial year ending December 31, 2025. The report is accessible through the “Investors” section of the Company's website and is available for download in PDF format. This release coincides with the convening of the Company's Annual Shareholders' Meeting, with all necessary documents provided in the "Shareholders Meetings" section online.
The company highlights its focus on acquiring majority stakes in European pharmaceutical subcontractors, aiming to form an integrated group servicing healthcare entities. Investors should note potential risks associated with forward-looking statements due to various uncertainties, as detailed in the Annual Report.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all OXURION news